151 related articles for article (PubMed ID: 18594872)
1. Comparison of high-performance liquid chromatography and enzyme-multiplied immunoassay technique to monitor mycophenolic acid in paediatric renal recipients.
Irtan S; Azougagh S; Monchaud C; Popon M; Baudouin V; Jacqz-Aigrain E
Pediatr Nephrol; 2008 Oct; 23(10):1859-65. PubMed ID: 18594872
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
Blanchet B; Taieb F; Conti F; Abbas H; Seydi I; Harcouet L; Dauphin A; Calmus Y; Tod M
Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of the Immunochemical Methods, PETINIA and EMIT, With That of HPLC-UV for the Routine Monitoring of Mycophenolic Acid in Heart Transplant Patients.
Kunicki PK; Pawiński T; Boczek A; Waś J; Bodnar-Broniarczyk M
Ther Drug Monit; 2015 Jun; 37(3):311-8. PubMed ID: 25380305
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy.
Weber LT; Shipkova M; Armstrong VW; Wagner N; Schütz E; Mehls O; Zimmerhackl LB; Oellerich M; Tönshoff B
Clin Chem; 2002 Mar; 48(3):517-25. PubMed ID: 11861442
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatography assay.
Beal JL; Jones CE; Taylor PJ; Tett SE
Ther Drug Monit; 1998 Dec; 20(6):685-90. PubMed ID: 9853989
[TBL] [Abstract][Full Text] [Related]
6. Establishment of high-performance liquid chromatography and enzyme multiplied immunoassay technology methods for determination of free mycophenolic acid and its application in Chinese liver transplant recipients.
Chen B; Gu Z; Chen H; Zhang W; Fen X; Cai W; Fan Q
Ther Drug Monit; 2010 Oct; 32(5):653-60. PubMed ID: 20814351
[TBL] [Abstract][Full Text] [Related]
7. Analytic validation of the enzyme multiplied immunoassay technique for the determination of mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatographic assay.
Hosotsubo H; Takahara S; Imamura R; Kyakuno M; Tanaka T; Yazawa K; Hanafusa T; Matsumiya K; Nonomura N; Okuyama A; Sugimoto H
Ther Drug Monit; 2001 Dec; 23(6):669-74. PubMed ID: 11802102
[TBL] [Abstract][Full Text] [Related]
8. Correlation between enzyme multiplied immunoassay technique and high-performance liquid chromatography in the quantification of voriconazole in a paediatric population.
Li X; Li W; Li M; Zhang Z; Liu S; Chen Z
Scand J Clin Lab Invest; 2021 Apr; 81(2):121-126. PubMed ID: 33426972
[TBL] [Abstract][Full Text] [Related]
9. Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry.
Prémaud A; Rousseau A; Picard N; Marquet P
Ther Drug Monit; 2006 Apr; 28(2):274-7. PubMed ID: 16628144
[TBL] [Abstract][Full Text] [Related]
10. Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring.
Prémaud A; Rousseau A; Le Meur Y; Lachâtre G; Marquet P
Ther Drug Monit; 2004 Dec; 26(6):609-19. PubMed ID: 15570184
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and protein binding of mycophenolic acid in stable lung transplant recipients.
Ensom MH; Partovi N; Decarie D; Dumont RJ; Fradet G; Levy RD
Ther Drug Monit; 2002 Apr; 24(2):310-4. PubMed ID: 11897977
[TBL] [Abstract][Full Text] [Related]
12. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
13. Age-related variability of mycophenolate mofetil exposure in stable pediatric liver transplant recipients and influences of donor characteristics.
Parant F; Rivet C; Boulieu R; Gagnieu MC; Dumortier J; Boillot O; Lachaux A
Ther Drug Monit; 2009 Dec; 31(6):727-33. PubMed ID: 19881404
[TBL] [Abstract][Full Text] [Related]
14. Lack of concordance between EMIT assay and LC-MS/MS for Therapeutic Drug Monitoring of Mycophenolic Acid: Potential increased risk for graft rejection?
De Nicolò A; Ianniello A; Benagli C; Della Bruna R; Keller F; Antonucci M; D'Avolio A; Cantù M
J Pharm Biomed Anal; 2020 Aug; 187():113337. PubMed ID: 32442868
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a Point-of-Care Testing with Enzyme-Multiplied Immunoassay Technique and Liquid Chromatography Combined With Tandem Mass Spectrometry Methods for Therapeutic Drug Monitoring of Mycophenolic Acid: A Preliminary Study.
Zhou H; Xiang H; Cai J; Wang Y; Zhang M; Han Y; Zhang Y
Ther Drug Monit; 2021 Oct; 43(5):630-636. PubMed ID: 33394991
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients.
Aw MM; Brown NW; Itsuka T; Gonde CE; Adams JE; Heaton ND; Tredger JM; Mieli-Vergani G; Dhawan A
Liver Transpl; 2003 Apr; 9(4):383-8. PubMed ID: 12682891
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolic acid monitoring in HTX patients: a preliminary report.
Müller MM; Vogl M; Griesmacher A
Therapie; 1997; 52(4):341-4. PubMed ID: 9437889
[TBL] [Abstract][Full Text] [Related]
18. Reliability of mycophenolic acid monitoring by an enzyme multiplied immunoassay technique.
Martiny D; Macours P; Cotton F; Thiry P; Gulbis B
Clin Lab; 2010; 56(7-8):345-53. PubMed ID: 20857899
[TBL] [Abstract][Full Text] [Related]
19. Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit.
Shipkova M; Schütz E; Armstrong VW; Niedmann PD; Oellerich M; Wieland E
Clin Chem; 2000 Mar; 46(3):365-72. PubMed ID: 10702523
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine.
Lobritto SJ; Rosenthal P; Bouw R; Leung M; Snell P; Mamelok RD
Liver Transpl; 2007 Nov; 13(11):1570-5. PubMed ID: 17969194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
